Drug repurposing for COVID-19 using computational screening: Is Fostamatinib/R406 a potential candidate?

With the gradual increase in the COVID-19 mortality rate, there is an urgent need for an effective drug/vaccine. Several drugs like Remdesivir, Azithromycin, Favirapir, Ritonavir, Darunavir, etc., are put under evaluation in more than 300 clinical trials to treat COVID-19. On the other hand, several...

Descripción completa

Detalles Bibliográficos
Autores principales: Saha, Sovan, Halder, Anup Kumar, Bandyopadhyay, Soumyendu Sekhar, Chatterjee, Piyali, Nasipuri, Mita, Bose, Debdas, Basu, Subhadip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390099/
https://www.ncbi.nlm.nih.gov/pubmed/34455072
http://dx.doi.org/10.1016/j.ymeth.2021.08.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390099/
https://www.ncbi.nlm.nih.gov/pubmed/34455072
http://dx.doi.org/10.1016/j.ymeth.2021.08.007

Ejemplares similares